Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Lei

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Acta Pharmaceutica Sinica. B|September 20, 2017
Establishment and characterization of arsenic trioxide resistant KB/ATO cellsYun-Kai Zhang, Chunling Dai, Chun-Gang Yuan, et al.
Immunopharmacology and Immunotoxicology|March 24, 2012
PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of α-momorcharin in vivoJue-cun Zheng, Ning Lei, Qian-chuan He, et al.
Frontiers in Cell and Developmental Biology|March 22, 2021
OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling PathwaysMin Zhao, Jiangyun Wang, Mei Qu, et al.
Frontiers in Oncology|July 18, 2020
Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer CellsYi-Dong Li, Yong Mao, Xing-Duo Dong, et al.
Frontiers in Oncology|June 2, 2020
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells <i>in vitro</i>Yuqi Yang, Ning Ji, Qiu-Xu Teng, et al.
Journal of Translational Internal Medicine|July 31, 2024
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cellsXing-Duo Dong, Qisi Lu, Yi-Dong Li, et al.
International Journal of Molecular Sciences|February 26, 2020
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer CellsJingqiu Wang, Dong-Hua Yang, Yuqi Yang, et al.
Biochemical Pharmacology|February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitorChao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Biochemical Pharmacology|June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.
Biochemical Pharmacology|May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cellsZhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Acta Pharmaceutica Sinica. B|September 20, 2017
Establishment and characterization of arsenic trioxide resistant KB/ATO cellsYun-Kai Zhang, Chunling Dai, Chun-Gang Yuan, et al.
Immunopharmacology and Immunotoxicology|March 24, 2012
PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of α-momorcharin in vivoJue-cun Zheng, Ning Lei, Qian-chuan He, et al.
Frontiers in Cell and Developmental Biology|March 22, 2021
OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling PathwaysMin Zhao, Jiangyun Wang, Mei Qu, et al.
Frontiers in Oncology|July 18, 2020
Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer CellsYi-Dong Li, Yong Mao, Xing-Duo Dong, et al.
Frontiers in Oncology|June 2, 2020
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells <i>in vitro</i>Yuqi Yang, Ning Ji, Qiu-Xu Teng, et al.
Journal of Translational Internal Medicine|July 31, 2024
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cellsXing-Duo Dong, Qisi Lu, Yi-Dong Li, et al.
International Journal of Molecular Sciences|February 26, 2020
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer CellsJingqiu Wang, Dong-Hua Yang, Yuqi Yang, et al.
Biochemical Pharmacology|February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitorChao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Biochemical Pharmacology|June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.
Biochemical Pharmacology|May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cellsZhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.
Pageof 14